The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cystic Fibrosis Treatment Market Research Report 2025

Global Cystic Fibrosis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1721235

No of Pages : 104

Ask Your Query
Synopsis
Cystic fibrosis (CF) is a hereditary disease characterized by abnormalities in the body's salt, aquatic cells, and mucus-producing cells.
The global Cystic Fibrosis Treatment market was valued at US$ 6701.8 million in 2023 and is anticipated to reach US$ 13800 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Treatment.
Report Scope
The Cystic Fibrosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actavis
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
Novo Nordisk
PharmaSwiss
Pharmaxis
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies
Segment by Type
Oral
Injection
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis Treatment Market Perspective (2019-2030)
2.2 Cystic Fibrosis Treatment Growth Trends by Region
2.2.1 Global Cystic Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cystic Fibrosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Cystic Fibrosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Cystic Fibrosis Treatment Market Dynamics
2.3.1 Cystic Fibrosis Treatment Industry Trends
2.3.2 Cystic Fibrosis Treatment Market Drivers
2.3.3 Cystic Fibrosis Treatment Market Challenges
2.3.4 Cystic Fibrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis Treatment Players by Revenue
3.1.1 Global Top Cystic Fibrosis Treatment Players by Revenue (2019-2024)
3.1.2 Global Cystic Fibrosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis Treatment Revenue
3.4 Global Cystic Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Cystic Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Treatment Revenue in 2023
3.5 Cystic Fibrosis Treatment Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis Treatment Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis Treatment Breakdown Data by Type
4.1 Global Cystic Fibrosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Type (2025-2030)
5 Cystic Fibrosis Treatment Breakdown Data by Application
5.1 Global Cystic Fibrosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cystic Fibrosis Treatment Market Size (2019-2030)
6.2 North America Cystic Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cystic Fibrosis Treatment Market Size by Country (2019-2024)
6.4 North America Cystic Fibrosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis Treatment Market Size (2019-2030)
7.2 Europe Cystic Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cystic Fibrosis Treatment Market Size by Country (2019-2024)
7.4 Europe Cystic Fibrosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Cystic Fibrosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cystic Fibrosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Cystic Fibrosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis Treatment Market Size (2019-2030)
9.2 Latin America Cystic Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cystic Fibrosis Treatment Market Size by Country (2019-2024)
9.4 Latin America Cystic Fibrosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Cystic Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cystic Fibrosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Cystic Fibrosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Actavis
11.1.1 Actavis Company Detail
11.1.2 Actavis Business Overview
11.1.3 Actavis Cystic Fibrosis Treatment Introduction
11.1.4 Actavis Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.1.5 Actavis Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Treatment Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Cystic Fibrosis Treatment Introduction
11.3.4 Gilead Sciences Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cystic Fibrosis Treatment Introduction
11.4.4 Novartis Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Vertex Pharmaceuticals
11.5.1 Vertex Pharmaceuticals Company Detail
11.5.2 Vertex Pharmaceuticals Business Overview
11.5.3 Vertex Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.5.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.5.5 Vertex Pharmaceuticals Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Cystic Fibrosis Treatment Introduction
11.6.4 Abbott Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Company Detail
11.7.2 Anthera Pharmaceuticals Business Overview
11.7.3 Anthera Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.7.4 Anthera Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.7.5 Anthera Pharmaceuticals Recent Development
11.8 Arcturus Therapeutics
11.8.1 Arcturus Therapeutics Company Detail
11.8.2 Arcturus Therapeutics Business Overview
11.8.3 Arcturus Therapeutics Cystic Fibrosis Treatment Introduction
11.8.4 Arcturus Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.8.5 Arcturus Therapeutics Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Cystic Fibrosis Treatment Introduction
11.9.4 Boehringer Ingelheim Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Chiesi Farmaceutici
11.10.1 Chiesi Farmaceutici Company Detail
11.10.2 Chiesi Farmaceutici Business Overview
11.10.3 Chiesi Farmaceutici Cystic Fibrosis Treatment Introduction
11.10.4 Chiesi Farmaceutici Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.10.5 Chiesi Farmaceutici Recent Development
11.11 Corbus Pharmaceuticals
11.11.1 Corbus Pharmaceuticals Company Detail
11.11.2 Corbus Pharmaceuticals Business Overview
11.11.3 Corbus Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.11.4 Corbus Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.11.5 Corbus Pharmaceuticals Recent Development
11.12 Genzyme
11.12.1 Genzyme Company Detail
11.12.2 Genzyme Business Overview
11.12.3 Genzyme Cystic Fibrosis Treatment Introduction
11.12.4 Genzyme Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.12.5 Genzyme Recent Development
11.13 Insmed
11.13.1 Insmed Company Detail
11.13.2 Insmed Business Overview
11.13.3 Insmed Cystic Fibrosis Treatment Introduction
11.13.4 Insmed Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.13.5 Insmed Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cystic Fibrosis Treatment Introduction
11.14.4 Johnson & Johnson Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.14.5 Johnson & Johnson Recent Development
11.15 Merck Sharp & Dohme
11.15.1 Merck Sharp & Dohme Company Detail
11.15.2 Merck Sharp & Dohme Business Overview
11.15.3 Merck Sharp & Dohme Cystic Fibrosis Treatment Introduction
11.15.4 Merck Sharp & Dohme Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.15.5 Merck Sharp & Dohme Recent Development
11.16 Neovii Biotech
11.16.1 Neovii Biotech Company Detail
11.16.2 Neovii Biotech Business Overview
11.16.3 Neovii Biotech Cystic Fibrosis Treatment Introduction
11.16.4 Neovii Biotech Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.16.5 Neovii Biotech Recent Development
11.17 Novo Nordisk
11.17.1 Novo Nordisk Company Detail
11.17.2 Novo Nordisk Business Overview
11.17.3 Novo Nordisk Cystic Fibrosis Treatment Introduction
11.17.4 Novo Nordisk Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.17.5 Novo Nordisk Recent Development
11.18 PharmaSwiss
11.18.1 PharmaSwiss Company Detail
11.18.2 PharmaSwiss Business Overview
11.18.3 PharmaSwiss Cystic Fibrosis Treatment Introduction
11.18.4 PharmaSwiss Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.18.5 PharmaSwiss Recent Development
11.19 Pharmaxis
11.19.1 Pharmaxis Company Detail
11.19.2 Pharmaxis Business Overview
11.19.3 Pharmaxis Cystic Fibrosis Treatment Introduction
11.19.4 Pharmaxis Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.19.5 Pharmaxis Recent Development
11.20 Proteostasis Therapeutics
11.20.1 Proteostasis Therapeutics Company Detail
11.20.2 Proteostasis Therapeutics Business Overview
11.20.3 Proteostasis Therapeutics Cystic Fibrosis Treatment Introduction
11.20.4 Proteostasis Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.20.5 Proteostasis Therapeutics Recent Development
11.21 PTC Therapeutics
11.21.1 PTC Therapeutics Company Detail
11.21.2 PTC Therapeutics Business Overview
11.21.3 PTC Therapeutics Cystic Fibrosis Treatment Introduction
11.21.4 PTC Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.21.5 PTC Therapeutics Recent Development
11.22 United Medical
11.22.1 United Medical Company Detail
11.22.2 United Medical Business Overview
11.22.3 United Medical Cystic Fibrosis Treatment Introduction
11.22.4 United Medical Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.22.5 United Medical Recent Development
11.23 Venus Remedies
11.23.1 Venus Remedies Company Detail
11.23.2 Venus Remedies Business Overview
11.23.3 Venus Remedies Cystic Fibrosis Treatment Introduction
11.23.4 Venus Remedies Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.23.5 Venus Remedies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock